Evidence map›Paper›PMID 35492512›Full record

ArticleRSC advances2019

Controlled release of basic fibroblast growth factor from a water-floatable polyethylene nonwoven fabric sheet for maintenance culture of iPSCs.

Ayako Oyane, Hiroko Araki, Maki Nakamura, Yasuhiko Aiki, Kumiko Higuchi, Alexander Pyatenko, Masaki Adachi, Yuzuru Ito

Abstract read
In one paragraph

Article in RSC advances, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ayako OyaneNanomaterials Research Institute, National Institute of Advanced Industrial Science and Technology (AIST) Central 5, 1-1-1 Higashi Tsukuba Ibaraki 305-8565 Japan a-oyane@aist.go.jp.ORCID https://orcid.org/0000-0001-6037-5558
Hiroko ArakiNanomaterials Research Institute, National Institute of Advanced Industrial Science and Technology (AIST) Central 5, 1-1-1 Higashi Tsukuba Ibaraki 305-8565 Japan a-oyane@aist.go.jp.
Maki NakamuraNanomaterials Research Institute, National Institute of Advanced Industrial Science and Technology (AIST) Central 5, 1-1-1 Higashi Tsukuba Ibaraki 305-8565 Japan a-oyane@aist.go.jp.
Yasuhiko AikiBiotechnology Research Institute for Drug Discovery, National Institute of Advanced Industrial Science and Technology (AIST) Central 6, 1-1-1 Higashi Tsukuba Ibaraki 305-8566 Japan.
Kumiko HiguchiBiotechnology Research Institute for Drug Discovery, National Institute of Advanced Industrial Science and Technology (AIST) Central 6, 1-1-1 Higashi Tsukuba Ibaraki 305-8566 Japan.
Alexander PyatenkoNational Institute of Advanced Industrial Science and Technology (AIST) Central 5, 1-1-1 Higashi Tsukuba Ibaraki 305-8565 Japan.
Masaki AdachiR&D Center, Katayama Chemical Industries Co., Ltd. 4-1-7 Ina Minoh Osaka 562-0015 Japan.
Yuzuru ItoBiotechnology Research Institute for Drug Discovery, National Institute of Advanced Industrial Science and Technology (AIST) Central 6, 1-1-1 Higashi Tsukuba Ibaraki 305-8566 Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Basic fibroblast growth factor (bFGF) is an essential supplement for culture media to support the proliferation of human pluripotent stem cells, while preserving their pluripotency. However, it is extremely unstable under cell culture conditions at 37 °C. Therefore, a culture medium supplemented with bFGF needs to be changed every day to maintain an effective concentration of bFGF. This study aimed to create a bFGF-releasing material

Identifiers

PMID35492512
PMCPMC9047564

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.